Solid Biosciences Inc.

Contributing Author

Recent Articles by Solid Biosciences Inc.

Nov-17	Solid Biosciences Announces Licensing Agreement with Andelyn Biosciences for the Use of Proprietary Next-Generation Capsid AAV-SLB101 SLDB GlobeNewswire
Nov-11	Solid Biosciences to Participate at Upcoming Investor Conferences SLDB GlobeNewswire
Nov-06	Solid Biosciences Awarded Innovation Passport Designation Under the New UK Innovative Licensing and Access Pathway for SGT-003, an Investigational Gene Therapy for Duchenne Muscular Dystrophy SLDB GlobeNewswire
Nov-04	Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) SLDB GlobeNewswire
Nov-03	Solid Biosciences Reports Third Quarter 2025 Financial Results and Provides Update on INSPIRE DUCHENNE Clinical Trial Progress and Planned Regulatory Discussions SLDB GlobeNewswire
Oct-30	Solid Biosciences to Participate at Upcoming Investor Conferences SLDB GlobeNewswire
Oct-01	Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) SLDB GlobeNewswire
Oct-01	Solid Biosciences to Present at Upcoming Scientific Meetings SLDB GlobeNewswire
Sep-25	Solid Biosciences to Present at 2025 Neuromuscular Study Group Annual Scientific Meeting SLDB GlobeNewswire
Sep-23	Solid Biosciences Announces Licensing Agreement with Kinea Bio for the Use of Proprietary Next-Generation Capsid AAV-SLB101 SLDB GlobeNewswire
Aug-28	Solid Biosciences to Participate at Upcoming Investor Conferences SLDB GlobeNewswire
Aug-12	Solid Biosciences Reports Second Quarter 2025 Financial Results and Provides Business Updates SLDB GlobeNewswire
Aug-01	Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) SLDB GlobeNewswire
Jul-23	Solid Biosciences Receives FDA Fast Track Designation for SGT-501 First-in-Class Gene Therapy for Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) SLDB GlobeNewswire
Jul-08	Solid Biosciences Announces FDA IND and Health Canada CTA Approval for First-in-Class Cardiac Gene Therapy to Treat Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) SLDB GlobeNewswire
Jul-01	Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) SLDB GlobeNewswire
Jun-03	Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) SLDB GlobeNewswire
May-28	Solid Biosciences to Participate at the Jefferies Global Healthcare Conference SLDB GlobeNewswire
May-15	Solid Biosciences Reports First Quarter 2025 Financial Results and Provides Business Updates SLDB GlobeNewswire
May-01	Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) SLDB GlobeNewswire

Solid Biosciences Inc.

Recent Articles by Solid Biosciences Inc.

Upgrade your FINVIZ experience